February 23 2023
Posted June 30, 2009
A US News and World Report article profiles a new test to determine the effectiveness of Alzheimer’s drugs developed by Cure Alzheimer’s Fund’s Dr. David Holtzman. The stable isotope-linked kinetics or SILK test quickly reveals whether medication is working to limit the harmful protein amyloid beta.
Click here to read full article
February 23 2023
February 14 2023
January 8 2023
December 13 2022
December 1 2022
October 7 2022